CTAB Enhances Chemo-Sensitivity Through Activation of AMPK Signaling Cascades in Breast Cancer

Metabolic reprogramming is thought to be one of the initiators in cancer drug resistance. It has been shown that CTAB is capable of interfering the efficiency of cancer therapy by regulation of cell metabolic reprogramming. In this study, we hypothesized that AMPK as a key metabolic regulator plays...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yue, Zhang, Yunqiu, Chen, Qing, Tao, Xufeng, Liu, Jianzhou, Xiao, Gary Guishan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676472/
https://www.ncbi.nlm.nih.gov/pubmed/31402869
http://dx.doi.org/10.3389/fphar.2019.00843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676472/
https://www.ncbi.nlm.nih.gov/pubmed/31402869
http://dx.doi.org/10.3389/fphar.2019.00843

Ejemplares similares